ADVERTISEMENT
Is India’s Competition Regulator Averse To Blocking Deals?
So far, CCI has looked at eight deals as part of Phase II investigations. Did none of them deserve to be blocked?
15 Jul 2019, 01:04 PM IST
From directing Sun-Ranbaxy to divest certain products back in 2015 to recently ordering behavioural remedies in L&T-Schneider deal, the Competition Commission of India’s approach in Phase II investigations has come a long way. If the regulator believes that on the face of it, a deal is likely to cause appreciable adverse effects on competition, it conducts a detailed investigation into the transaction. This, in competition law parlan...
I’m already a Subscriber Sign In
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Ad-Lite
Experience
Members-Only
Rewards
NDTV Profit
Exclusive Stories
Full Access to
NDTV Profit App
Access to
Stories
20,000+
Research Reports
Ad-Lite
Experience
NDTV Profit
Exclusive Stories
Curated
Newsletters
Priority Pass
to Special Events
Members-Only
Rewards
Full Access to
NDTV Profit App
Still Not convinced ? Know More
Get live Stock market updates, Business news, Today’s latest news, Trending stories, and Videos on NDTV Profit.
ADVERTISEMENT